Johan Hansson Selected Research

Johan Hansson Research Topics

Disease

76	Melanoma (Melanoma, Malignant) 01/2022 - 05/2002
36	Neoplasms (Cancer) 10/2020 - 11/2002
15	Neoplasm Metastasis (Metastasis) 10/2019 - 09/2002
10	Cutaneous Malignant Melanoma 10/2020 - 12/2002
5	Lymphatic Metastasis 10/2018 - 08/2010
5	Wounds and Injuries (Trauma) 06/2013 - 04/2011
3	Skin Neoplasms (Skin Cancer) 01/2020 - 11/2005
3	Basal Cell Carcinoma (Rodent Ulcer) 12/2018 - 11/2005
3	Uveal melanoma 08/2015 - 10/2006
2	Disease Progression 01/2022 - 01/2017
2	Urinary Bladder Neoplasms (Bladder Cancer) 06/2017 - 01/2017
2	Fever (Fevers) 08/2015 - 11/2014
2	Nevus (Nevi) 07/2010 - 11/2005
1	COVID-19 01/2023
1	Sunburn 01/2021
1	Bullous Pemphigoid (Pemphigoid) 11/2020
1	Pathologic Processes 10/2020
1	Colitis 01/2019
1	Inflammation (Inflammations) 01/2018
1	Breast Neoplasms (Breast Cancer) 12/2017
1	Pain (Aches) 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2015

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2002
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2011
6	Codon (Codons)IBA 01/2009 - 11/2002
5	Mitogen-Activated Protein KinasesIBA 01/2020 - 12/2003
4	IpilimumabIBA 01/2019 - 11/2011
4	MicroRNAs (MicroRNA)IBA 01/2018 - 08/2010
4	Small Interfering RNA (siRNA)IBA 12/2017 - 05/2005
4	InterferonsIBA 01/2016 - 10/2007
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2014 - 04/2008
4	Tumor Suppressor Protein p14ARF (p14ARF)IBA 10/2006 - 06/2002
3	NivolumabIBA 01/2021 - 01/2019
3	Messenger RNA (mRNA)IBA 10/2020 - 11/2011
3	dabrafenibIBA 06/2017 - 11/2014
3	DNA (Deoxyribonucleic Acid)IBA 06/2015 - 06/2003
3	Temozolomide (Temodar)FDA LinkGeneric 06/2015 - 08/2006
3	Dacarbazine (DIC)FDA LinkGeneric 06/2015 - 09/2002
3	Cisplatin (Platino)FDA LinkGeneric 10/2013 - 05/2002
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 06/2011 - 12/2003
2	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2013
2	Immune Checkpoint InhibitorsIBA 11/2020 - 09/2014
2	VemurafenibIBA 10/2020 - 08/2016
2	KynurenineIBA 01/2020 - 01/2019
2	HLA-A Antigens (HLA-A)IBA 01/2019 - 10/2009
2	Peptides (Polypeptides)IBA 01/2019 - 05/2011
2	EnzymesIBA 01/2019 - 06/2009
2	HhAntag691IBA 12/2018 - 06/2015
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2018 - 04/2012
2	CarcinogensIBA 11/2016 - 02/2004
2	ScandiumIBA 08/2015 - 08/2014
2	trametinibIBA 08/2015 - 11/2014
2	MethyltransferasesIBA 06/2015 - 09/2002
2	Interferon-alpha (Interferon Alfa)IBA 06/2015 - 02/2013
2	Monoclonal AntibodiesIBA 04/2015 - 11/2011
2	ParaffinIBA 04/2015 - 10/2014
2	Formaldehyde (Formol)FDA Link 04/2015 - 10/2014
2	Interferon alpha-2 (Roferon-A)FDA Link 02/2015 - 02/2011
2	IntegrinsIBA 09/2014 - 05/2011
2	Laminin (Merosin)IBA 09/2014 - 05/2011
2	Protein Isoforms (Isoforms)IBA 09/2014 - 05/2011
2	ORALIT (ORS)IBA 05/2014 - 02/2009
2	HLA-DR Antigens (HLA-DR)IBA 07/2013 - 06/2010
2	Type 1 Melanocortin ReceptorIBA 08/2012 - 04/2009
2	Cyclin-Dependent Kinase Inhibitor p16IBA 12/2010 - 06/2003
1	ciclesonide FDA Link 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	Sunscreening Agents (Sunscreens)IBA 01/2021
1	Antisense RNA (Anti-Sense RNA)IBA 01/2021
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 10/2020
1	CrizotinibIBA 10/2020
1	AfatinibIBA 10/2020
1	Insulin (Novolin)FDA Link 10/2020
1	Transcription Factors (Transcription Factor)IBA 10/2020
1	karonudibIBA 01/2020
1	pembrolizumabIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	tyrosine receptor (receptor, tyrosine)IBA 10/2019
1	Phosphotransferases (Kinase)IBA 10/2019
1	Histocompatibility Antigens Class IIBA 01/2019
1	EpitopesIBA 01/2019
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2018
1	TEMPOIBA 01/2018
1	ElementsIBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 12/2017
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 12/2017
1	1-methyl-1-piperidinomethane sulfonateIBA 11/2017
1	ProteomeIBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	OsteopontinIBA 06/2015
1	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2015
1	Bevacizumab (Avastin)FDA Link 04/2015

Therapy/Procedure

28	Therapeutics 01/2023 - 11/2002
7	Immunotherapy 01/2021 - 08/2006
4	Negative-Pressure Wound Therapy 04/2012 - 04/2011
3	Drug Therapy (Chemotherapy) 01/2017 - 09/2002
2	Palliative Care (Palliative Therapy) 11/2018 - 01/2017
1	Neoadjuvant Therapy 06/2017